Clinical trial
Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy
NCT03388619
Study timeline
Study start (actual)2018-01-17Date precision: day
Registry last updated2026-08-28
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Cancer Of Prostateunresolved
Prostate Neoplasmsunresolved
Prostate Cancerunresolved
Neoplasms of Prostateunresolved
Prostatic Cancerunresolved
Interventions
Prostate bed with integrated boostRADIATION
Prostate bed irradiation onlyRADIATION
Whole Body Bone ScanDIAGNOSTIC_TEST
18F-NaF PET ImagingDIAGNOSTIC_TEST
CTDIAGNOSTIC_TEST
mpMRIDIAGNOSTIC_TEST
ADTDRUG
Sponsors & collaborators
National Cancer Institute (NCI)lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03388619 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.